Akorn Holding Company LLC
Case Number:
1:23-bk-10253
Court:
Nature of Suit:
Firms
- Klehr Harrison
- Porzio Bromberg
- Ciardi Ciardi
- Tucker Arensberg
- Barnes & Thornburg
- Law Office of James Tobia
- Potter Anderson
- Margolis Edelstein
- McElroy Deutsch
- Dickie McCamey
- Connolly Gallagher
- Landis Rath
- Chipman Brown
- Faegre Drinker
- Kirkland & Ellis
- Pierson Ferdinand LLP
- Richards Layton
- Morris Nichols
- Pachulski Stang
- Kramer Levin
- Bielli & Klauder
- Pashman Stein
- Powell Firm
- Jacob & Weingarten
- Saul Ewing
- Taft Stettinius
- Windels Marx
- Foley Hoag
- A. M. Saccullo Legal
- Buchanan Ingersoll
- Glenn Agre
- Morris James
- Baker Botts
- Kilpatrick Townsend
- Troutman
- Ashby & Geddes
- Law Office of Susan E. Kaufman
- Buchalter APC
- Flaster Greenberg
- Paul Hastings
- Womble Bond
- Clark Hill
- Ballard Spahr
- Chiesa Shahinian
- Hackett Feinberg
- Duane Morris
- Cozen O'Connor
- Greenberg Traurig
- Lewis Brisbois
- Weil Gotshal
- Gibson Dunn
- Lowenstein Sandler
- Proskauer Rose
- Archer & Greiner
- Sequor Law
- Kaplan & Gournis
- McCarter & English
- Young Conaway
- K&L Gates
- Fox Rothschild
- Manier & Herod
- Whiteford Taylor
- Latham & Watkins
Companies
- Particle Measuring Systems Inc.
- Hikma Pharmaceuticals PLC
- SGS SA
- Evoqua Water Technologies LLC
- Syneos Health Inc.
- Ethypharm S.A.
- Iron Mountain Inc.
- Loomis Sayles & Co. LP
- Leadiant Biosciences Inc.
- Aurobindo Pharma Ltd.
- Hain Capital Group LLC
- TR Capital Management LLC
- Prestige Consumer Healthcare Inc.
- GSMS Inc.
- Commonwealth Edison Co.
- Akorn Inc.
- Cardinal Health Inc.
- McKesson Corp.
- Fareva SA
- Managed Health Care Associates Inc.
- Cencora Inc.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Credit Suisse Group AG
- Heritage Global Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Texas Comptroller of Public Accounts
- U.S. Customs and Border Protection
- Oregon Health Authority
- New York State Department of Health
Sectors & Industries:
-
August 23, 2024
Drug Cos. Akorn, Cardinal Settle $28M Ch. 7 Fight
Defunct drug manufacturer Akorn has told Delaware's bankruptcy court it reached an agreement resolving a roughly $28 million dispute regarding its prepetition sale of pharmaceuticals to distributor Cardinal Health, which promised to pay nearly $7 million to the debtor's Chapter 7 estate.
-
February 24, 2023
Akorn Files For Ch. 7 Liquidation With Over $100M Debt
Remnants of recently bankrupt specialty pharmaceutical venture Akorn Pharmaceuticals and two affiliates have crossed over from Chapter 11 to Chapter 7 liquidation in Delaware, with a worker complaint in tow alleging violations of federal plant closing and layoff regulations.